Clarendon Pharma Limited - Accounts to registrar (filleted) - small 22.3

Clarendon Pharma Limited - Accounts to registrar (filleted) - small 22.3


IRIS Accounts Production v22.4.0.132 01639374 Board of Directors 1.10.21 31.7.22 31.7.22 false true false false false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure016393742021-09-30016393742022-07-31016393742021-10-012022-07-31016393742020-09-30016393742020-10-012021-09-30016393742021-09-3001639374ns16:EnglandWales2021-10-012022-07-3101639374ns15:PoundSterling2021-10-012022-07-3101639374ns11:Director12021-10-012022-07-3101639374ns11:PrivateLimitedCompanyLtd2021-10-012022-07-3101639374ns11:Micro-entities2021-10-012022-07-3101639374ns11:AuditExempt-NoAccountantsReport2021-10-012022-07-3101639374ns11:FullAccounts2021-10-012022-07-3101639374ns6:CurrentFinancialInstruments2022-07-3101639374ns6:CurrentFinancialInstruments2021-09-3001639374ns11:RegisteredOffice2021-10-012022-07-31
REGISTERED NUMBER: 01639374 (England and Wales)











Financial Statements

for the Period 1 October 2021 to 31 July 2022

for

CLARENDON PHARMA LIMITED

CLARENDON PHARMA LIMITED (REGISTERED NUMBER: 01639374)






Contents of the Financial Statements
for the Period 1 October 2021 to 31 July 2022




Page

Balance Sheet 1


CLARENDON PHARMA LIMITED (REGISTERED NUMBER: 01639374)

Balance Sheet
31 July 2022

31.7.22 30.9.21
£    £    £    £   
FIXED ASSETS - 14,100

CURRENT ASSETS 37,432 64,628

CREDITORS
Amounts falling due within one year (13,019 ) (7,235 )
NET CURRENT ASSETS 24,413 57,393
TOTAL ASSETS LESS CURRENT
LIABILITIES

24,413

71,493

CAPITAL AND RESERVES 24,413 71,493

NOTES TO THE FINANCIAL STATEMENTS

1. STATUTORY INFORMATION

Clarendon Pharma Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 01639374

Registered office: 19 King Street
Seagrave
Leicester
Leicestershire
LE12 7LY

2. AVERAGE NUMBER OF EMPLOYEES

The average number of employees during the period was 1 (2021 - 1 ) .



The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 31 July 2022.

The members have not required the company to obtain an audit of its financial statements for the period ended 31 July 2022 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

CLARENDON PHARMA LIMITED (REGISTERED NUMBER: 01639374)

Balance Sheet - continued
31 July 2022


The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the Board of Directors and authorised for issue on 10 February 2023 and were signed on its behalf by:





AC Allen - Director